(Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | |
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets | ||||||||
Cash, cash equivalents and short term investments | 316.18%1.38M | 4.48%383.96K | 4.48%383.96K | --480.93K | --555.91K | --330.54K | --367.51K | --367.51K |
-Cash and cash equivalents | 316.18%1.38M | 4.48%383.96K | 4.48%383.96K | --480.93K | --555.91K | --330.54K | --367.51K | --367.51K |
Total current assets | 316.18%1.38M | 4.48%383.96K | 4.48%383.96K | --480.93K | --555.91K | --330.54K | --367.51K | --367.51K |
Non current assets | ||||||||
-Other intangible assets | ---- | --1.05K | --1.05K | --258.95K | --258.95K | --26.2K | ---- | ---- |
Liabilities | ||||||||
Current liabilities | ||||||||
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Current liabilities | -9.25%14.52K | -36.12%35.77K | -36.12%35.77K | --20.55K | --20.55K | --16K | --56K | --56K |
Non current liabilities | ||||||||
Non current accrued expenses | 0.00%1 | 0.00%1 | 0.00%1 | --1 | --1 | --1 | --1 | --1 |
Total non current liabilities | -9.25%14.52K | -36.12%35.77K | -36.12%35.77K | --20.55K | --20.55K | --16K | --56K | --56K |
Shareholders'equity | ||||||||
Share capital | 281.65%1.89M | 52.35%754.15K | 52.35%754.15K | --495K | --495K | --495K | --495K | --495K |
-common stock | 281.65%1.89M | 52.35%754.15K | 52.35%754.15K | --495K | --495K | --495K | --495K | --495K |
Gains losses not affecting retained earnings | --44.2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total equity | 316.18%1.38M | 4.48%383.96K | 4.48%383.96K | --480.93K | --555.91K | --330.54K | --367.51K | --367.51K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.